Evidence map›Paper›PMID 30046202›Full record

ReviewIranian journal of medical sciences2018

Prevalence of

Ebrahim Eskandari-Nasab, Mehdi Moghadampour, Arezoo Tahmasebi

Open access · greenAbstract readReview
In one paragraph

Review in Iranian journal of medical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Beta-lactamase resistance genes inAfrican journal of laboratory medicine · 2022
    Review
  3. Article
  4. Frequency of Beta-Lactamase Antibiotic Resistance Genes inEthiopian journal of health sciences · 2021
    Article
  5. Review
  6. Phenotypic and Molecular Characterization ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Ebrahim Eskandari-NasabGenetic of Non-Communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Mehdi MoghadampourDepartment of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Arezoo TahmasebiDepartment of Statistical and Actuarial Sciences, University of Western Ontario (UWO), London, ON, Canada.
Isfahan University of Medical Sciences · IRWestern University · CAZahedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCTX-M-type extended-spectrum β-lactamases (ESBLs) are the most prevalent ESBLs in bacterial members of Enterobacteriaceae family including

methodsA comprehensive literature search of studies published up to July 2016 was carried out. The keywords "Enterobacteriaceae", "

resultsTwenty-four articles/abstracts were included in this analysis. Selected studies were performed in Ahvaz, Arak, Ilam, Kashan, Kerman, Mashhad, Shiraz, Tabriz, Tehran, Zabol, and Zahedan. Our pooled evidence showed that the RF of blaCTX-M gene among ESBLs-producing

conclusionOur meta-analysis revealed that the RF of CTX-M-type ESBLs-producing

Indexed as

blaCTX-MCTX-MExtended-spectrum beta-lactamaseKlebsiella pneumoniae

Identifiers

PMID30046202
PMCPMC6055219
OpenAlexW2739411864

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.